TomoTherapy Incorporated 

(Public, NASDAQ:TOMO)   Watch this stock   
Find more results for TOMO
Dec 1, 2009
Piper Jaffray Healthcare Conference - 11:00AM EST - Add to calendar
Nov 2, 2009
Analyst and Investor Meeting at ASTRO 2009 - Webcast
Oct 28, 2009
Q3 2009 Earnings Conference Call - Webcast
Oct 28, 2009
Q3 2009 Earnings Release
Sep 11, 2009
Thomas Weisel Partners Healthcare Conference
Sep 10, 2009
Robert W. Baird & Co., Inc. Health Care Conference
Sep 9, 2009
Citigroup Investment Research's 3rd Annual Radiation Oncology Seminar on Radiosurgery and Radiation Therapy
Sep 9, 2009
Citigroup Investment Research's 3rd Annual Radiation Oncology Seminar on Proton Therapy
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -45.62% -19.84%
Operating margin -46.92% -19.25%
EBITD margin - -15.01%
Return on average assets -23.25% -13.06%
Return on average equity -29.28% -14.78%
Employees 748 -

Address

1240 Deming Way
Madison, WI 53717-1954
United States - Map
+1-608-8242800 (Phone)
+1-608-8242996 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

TomoTherapy Incorporated discussions

  View all discussions »

Description

TomoTherapy Incorporated develops, manufactures, markets and sells the Hi-Art system, a radiation therapy system for the treatment of a range of cancer types. The Company manufactures each Hi Art system in a 64,000 square foot facility in Madison, Wisconsin. The Hi Art system combines integrated computerized tomography (CT) imaging with radiation therapy to deliver radiation treatment while reducing radiation exposure to surrounding healthy tissue.It markets and sell the Hi Art system to hospitals and cancer treatment centers in North America, Europe, the Middle East and Asia-Pacific, and offer customer support services in each region. North America, Europe and Asia-Pacific accounted for 67%, 24% and 9%, respectively, of the Company's revenue during the year ended December 31, 2008. On October 31, 2008, the Company acquired Chengdu Twin Peak Accelerator Technology Inc. (Twin Peak), a privately held company based in Chengdu, China.

Officers and directors

Thomas Rockwell Mackie Ph.D.
Chairman of the Board
Age: 54
Bio & Compensation - Reuters
Frederick A. Robertson M.D.
President, Chief Executive Officer, Director
Age: 53
Bio & Compensation - Reuters
Thomas E. Powell
Chief Financial Officer, Treasurer
Age: 48
Bio & Compensation - Reuters
Brenda S. Furlow J.D.
Vice President, General Counsel, Secretary
Age: 50
Bio & Compensation - Reuters
John J. McDonough
Director
Age: 72
Bio & Compensation - Reuters
Cary J. Nolan
Director
Age: 66
Bio & Compensation - Reuters
Carlos A. Perez M.D.
Director
Age: 74
Bio & Compensation - Reuters
Sam R. Leno
Director
Age: 63
Bio & Compensation - Reuters
Frances S. Taylor
Director
Age: 62
Bio & Compensation - Reuters